muscarinic receptor

New, Potential First-in-Class Schizophrenia Medicine Reduced Positive and Negative Symptoms in Phase 3 Trial
New, Potential First-in-Class Schizophrenia Medicine Reduced Positive and Negative Symptoms in Phase 3 Trial
A new medicine for treating schizophrenia—one that appears to help reduce both positive and negative symptoms of the illness—has passed a first hurdle in phase 3 clinical testing. Phase 3 is often… Read More

TOPICS

Tags

1997
25 Years of Breakthroughs
Addiction
Aging
Alcohol Addiction
Alcohol Use Disorder
allopregnanolone
Alzheimer's Disease
Amygdala
anhedonia
Anorexia Nervosa
antidepressants
antipsychotics
Anxiety
aripiprazole
ASD
Asperger's Syndrome
auditory cortex
Autism
Baclofen
Basal Ganglia
behavioral therapy
Big Data
Binge Eating Disorder
biofeedback
Biomarkers
bipolar depression
Bipolar Disorder
birth complications
Blog
blood-brain barrier
borderline personality disorder
Brain & Behavior Magazine
Brain & Behavior Magazine July 2017
Brain & Behavior Magazine March 2018
Brain & Behavior Magazine September 2018
brain aging
brain circuits
brain development
brain fog
Brain Imaging
brain mapping
brain networks
brain scans
Brain Stimulation
brain waves
brainwaves
brexanolone
bright-light therapy
Bulimia
Bulimia Nervosa
Bullying
canakinumab
Cannabis
CBT
cell biology
Children & Adolescents
choline
Cocaine
Cognition
cognitive behavioral therapy
cognitive decline
cognitive deficits
Cognitive Dysfunction
cognitive function
Cognitive Impairment
cognitive remediation
cognitive symptoms
cognitive training
combat
Conduct Disorder
Copy-Number Variations
COVID-19
CRISPR
D2 receptor
DBS
DBT
dementia
Developmental Disorders
diabetes
Diet
Dietary Supplements
Discrimination
disruptive mood dysregulation disorder
Dopamine
Drug Addiction
DTI
early life trauma
Eating Disorders
ECT
EEG
electrical stimulation
electroconvulsive therapy
Electronic Media Use
Epigenetics
epilepsy
events
excitation/inhibition balance
excitatory neurons
exercise & mental health
exposure therapy
eye-tracking
fast-acting antidepressants
Fear
Fear Memory
fetal brain development
fMRI
Folic Acid
Foster Care
Fragile X Syndrome
fundraising
GABA
Gender Differences
Genetics
Genome
Geriatric Mental Health
Germany
glutamate
Grants
gut
GWAS
hippocampus
hormones
hypomania
imaging
Immune System
Impulse Control
individualized treatments
Infection & Mental illness
Inflammation
inhibitory neurons
insomnia
Intellectual Disability
iPCS
iTBS
KarXT
ketamine
Lateral Habenula
light therapy
lithium
loneliness
longitudinal studies
machine learning
magnet seizure therapy
major depressive disorder
mania
Marijuana
maternal health
memory
Memory Loss
menstrual cycle
Mental Illness (General)
mental-illness multiple
Metabolic Disorders
Metabolic Syndrome
Metabolism
Microbiome
mindfulness
mitochondria
Mood Disorders
mood stabilizers
Motivation
MST
mu receptor
multiple sclerosis
muscarinic receptor
Myelination
NARSAD Artworks
Negative Symptoms
neural networks
Neurodegenerative Disorders
neurodevelopmental illness
Neurofeedback
neurogenesis
Neuroimaging
neurons
neuroticism
neurotransmitters
nitrous oxide
noninvasive stimulation
Obesity
opioids
organoids
oxytocin
pandemic
panic disorder
Parenting
Parkinson's Disease
perinatal period
PET
PGC
phone-based apps
placebo effect
Plasticity/Neuroplasticity
PMDD
Positive Symptoms
Postpartum Depression
prefrontal cortex
pregnancy
Prevention
psychedelics
Psychosis
Psychotherapy
PTSD
rapid-acting antidepressants
recovery
Resilience
Rett Syndrome
reward system
rumination
SAINT
SCHEMA
schizoaffective
schizotypal personality disorder
Screen Time
Seizures
self-esteem training
serotonin
side effects
sleep
sleep disorders
social anxiety
social brain
social communication
Spain
SRI
SSRI
stem cells
Stress
striatum
Substance Abuse
suicidal thinking
suicide
suicide prevention
suicide risk
symposium
synapses
Talk Therapy
tDCS
team up
THC
tic disorder
Timothy syndrome
tobacco
Tourette syndrome
Transcranial Magnetic Stimulation (TMS)
Trauma
traumatic brain injury
treatment response
treatment-resistant depression
tsDCS
vagus nerve stimulation
veterans
video
vitamin d
VNS
webinar
White Matter/Grey Matter
zuranolone
Close menu
Brain & Behavior
Grants & Prizes
Home
Research
Illness
Addiction
Attention-Deficit Hyperactivity Disorder (ADHD)
Autism Spectrum Disorder (ASD)
Anxiety Disorders
Bipolar Disorder
Borderline Personality Disorder (BPD)
Depression
Eating Disorders
Inaccessible
Mental Illness (General)
Obsessive-Compulsive Disorder (OCD)
Post-Traumatic Stress Disorder (PTSD)
Schizophrenia
Suicide Prevention
Category
New Technologies
Next Generation Therapies
Basic Research
Early Intervention/ Diagnostic Tools
Blog
Get Involved
Give
Find an Event/Memorial Page
Make a Memorial/Tribute Gift
Create an Event/Memorial Page
Donate Cryptocurrency
Donate Today
Get Involved
Make a Stock/Securities Gift/IRA Charitable Rollover Gift
Other Giving Opportunities
Monthly Giving
Planned Giving
Sponsorship Opportunities
Team Up for Research!
Donor Advised Funds
Research Partners
Workplace Matching Gifts
Watch
Healthy Minds TV
Meet the Scientist Webinars
Videos
Connect
Ask the Expert
Join Us
About Us
FAQs
Our Impact
Who We Are
Media Center
News
Media Kit
Multimedia Library
Press Releases
In the News
Opinion Pieces
Events & Webinars
Events & Webinars
Team Up for Research! Events
Healthy Minds TV
Contact
Email Signup